5/19/23 16:18  | 5/19/23  | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | DE | D |  | M.d | 0 | 0.00 | 0 | 4 | 0 | 3,582 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/23 16:18  | 5/19/23  | PHAS | Health | Drug | Pharmaceutical Preparations | Humphries William D. | DE | D |  | M.d | 0 | 0.00 | 0 | 3 | New | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/23 16:17  | 5/19/23  | PHAS | Health | Drug | Pharmaceutical Preparations | Harrigan Edmund | DE | D |  | M.d | 0 | 0.00 | 0 | 4 | 63 | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/23 16:17  | 5/19/23  | PHAS | Health | Drug | Pharmaceutical Preparations | Sapir Alex | DE | D |  | M.d | 0 | 0.00 | 0 | 4 | New | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/23 16:16  | 5/19/23  | PHAS | Health | Drug | Pharmaceutical Preparations | Loewy Caroline M | DE | D |  | M.d | 0 | 0.00 | 0 | 4 | New | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/23 16:15  | 5/19/23  | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | DE | D |  | M.d | 0 | 0.00 | 0 | 4 | 10 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/26/22 16:41  | 10/25/22  | PHAS | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T |  | S | -262 | 0.1470 | 0 | -1,784 | -27 | 4,858 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/24/22 17:14  | 5/23/22  | PHAS | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | SVP of H | S | -9 | 0.7900 | 0 | -11 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/20/22 16:47  | 8/18/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D |  | P.a | 9 | 3.08 | 0 | 3 | 9 | 38 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/23/21 18:50  | 11/19/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | VP,HR | S | -14 | 2.37 | 0 | -6 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/8/21 18:26  | 11/5/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D |  | M.dm | 84 | 2.49 | 0 | 34 | New | 34 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/3/21 19:30  | 11/3/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | M.d | 25 | 1.24 | 0 | 20 | 14 | 167 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/3/21 19:30  | 11/3/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Sharp John P | PA | O | CFO | M.d | 13 | 1.68 | 0 | 8 | 15 | 58 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/21 16:43  | 7/12/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Arnold Susan Elizabeth | PA | O | VP,Precl | M.ad | 8 | 1.74 | 0 | 5 | 19 | 28 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/21 16:41  | 8/3/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Sharp John P | PA | O | CFO | M.ad | 13 | 1.68 | 0 | 8 | 18 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/30/21 17:52  | 8/27/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | M.d | 25 | 1.24 | 0 | 20 | 16 | 147 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/19/21 16:24  | 8/18/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D |  | P | 9 | 3.08 | 0 | 3 | 300 | 4 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/21 18:07  | 8/18/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | D |  | P | 30 | 3.00 | 0 | 10 | 44 | 33 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/24/21 18:11  | 5/20/21  | PHAS | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | VP,HR | S | -13 | 3.29 | 0 | -4 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/4/20 15:53  | 12/3/20  | PHAS | Health | Drug | Pharmaceutical Preparations | Harrigan Edmund | PA | D |  | P | 25 | 4.12 | 0 | 6 | New | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/24/20 16:04  | 11/23/20  | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | D |  | P.m | 18 | 3.60 | 0 | 5 | 28 | 23 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/23/20 18:27  | 11/23/20  | PHAS | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | VP,HR | S | -12 | 3.45 | 0 | -3 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/5/20 21:08  | 2/27/20  | PHAS | Health | Drug | Pharmaceutical Preparations | Arnold Susan Elizabeth | PA | O | VP,Precl | M.dm | 12 | 1.15 | 0 | 11 | 470 | 13 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/24/20 19:04  | 8/21/20  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | M.d | 12 | 1.24 | 0 | 10 | 9 | 119 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/17/20 20:15  | 8/14/20  | PHAS | Health | Drug | Pharmaceutical Preparations | Sharp John P | PA | O | CFO | M.d | 8 | 1.69 | 0 | 5 | 14 | 40 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/10/19 16:10  | 9/6/19  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | M.d | 24 | 1.24 | 0 | 19 | 21 | 109 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/22/19 19:42  | 8/21/19  | PHAS | Health | Drug | Pharmaceutical Preparations | Sharp John P | PA | O | CFO,Secr | M.d | 24 | 1.61 | 0 | 15 | 75 | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/3/19 16:28  | 7/1/19  | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | DT |  | S | -41 | 14.00 | 0 | -3 | 0 | 2,450 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/20/19 19:09  | 6/18/19  | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | DT |  | S | -6 | 14.00 | 0 | 0 | 0 | 2,453 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/24/19 14:22  | 5/22/19  | PHAS | Health | Drug | Pharmaceutical Preparations | Sharp John P | PA | O | CFO,Secr | M.d | 25 | 1.69 | 0 | 15 | 300 | 20 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/21/19 18:27  | 5/17/19  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | M.dm | 69 | 1.77 | 0 | 39 | 76 | 90 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/17/18 16:24  | 12/13/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Ballance David James | PA | O | VP,Resea | P | 4 | 3.94 | 0 | 1 | 15 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/17/18 16:19  | 12/17/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D |  | P | 4 | 4.46 | 0 | 1 | New | 1 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/17/18 16:18  | 12/13/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | P | 4 | 3.69 | 0 | 1 | 2 | 51 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/13/18 17:04  | 12/7/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | P.am | 6 | 3.87 | 0 | 2 | 3 | 50 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/11/18 16:18  | 12/11/18  | PHAS | Health | Drug | Pharmaceutical Preparations | York Michael | PA | O | VP,Corpo | P | 6 | 3.88 | 0 | 2 | New | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/11/18 16:16  | 12/7/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Sharp John P | PA | O | CFO,Secr | P | 19 | 3.84 | 0 | 5 | New | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/11/18 16:12  | 12/7/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | P.m | 12 | 3.87 | 0 | 3 | 6 | 52 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/6/18 09:15  | 12/4/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | DT |  | P | 13 | 3.13 | 0 | 4 | 0 | 2,474 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/24/18 17:01  | 10/22/18  | PHAS | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T |  | P.d | 9,000 | 5.00 | 0 | 1,800 | 37 | 6,642 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/24/18 16:20  | 10/22/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Tufts Linda | PA | D |  | P.d | 100 | 5.00 | 0 | 20 | 2 | 931 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/24/18 16:19  | 10/22/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | DT |  | P.d | 1,500 | 5.00 | 0 | 300 | 14 | 2,470 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/24/18 16:18  | 10/22/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Hatteras Venture Advisors Iii, LLC | NC | T |  | P.d | 1,500 | 5.00 | 0 | 300 | 14 | 2,458 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/24/18 16:16  | 10/22/18  | PHAS | Health | Drug | Pharmaceutical Preparations | Astrazeneca Plc | X0 | T |  | P.d | 3,000 | 5.00 | 0 | 600 | 25 | 3,005 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  |